ICD-10 Code C79.32

Secondary malignant neoplasm of cerebral meninges

Version 2019 Billable Code Neoplasm Malignant Secondary
ICD-10:C79.32
Short Description:Secondary malignant neoplasm of cerebral meninges
Long Description:Secondary malignant neoplasm of cerebral meninges

Valid for Submission

ICD-10 C79.32 is a billable code used to specify a medical diagnosis of secondary malignant neoplasm of cerebral meninges. The code is valid for the year 2019 for the submission of HIPAA-covered transactions.

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
      • Secondary malignant neoplasm of other and unspecified sites (C79)

Information for Medical Professionals

Convert C79.32 to ICD-9

The following crosswalk between ICD-10 to ICD-9 is based based on the General Equivalence Mappings (GEMS) information:

  • 198.4 - Sec malig neo nerve NEC (Approximate Flag)

Synonyms

The following clinical terms are approximate synonyms:

  • Malignant neoplasm of cerebral meninges
  • Metastatic malignant neoplasm of meninges
  • Neoplasm of cerebral meninges
  • Secondary malignant neoplasm of cerebral meninges

Table of Neoplasms

The code C79.32 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

The Tabular must be reviewed for the complete diagnosis code.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»arachnoid
  »cerebral
C70.0C79.32D32.0D42.0D49.7
»brain NEC
  »meninges
C70.0C79.32D32.0D42.0D49.7
»cerebrum, cerebral (cortex) (hemisphere) (white matter)
  »meninges
C70.0C79.32D32.0D42.0D49.7
»cranial (fossa, any)
  »meninges
C70.0C79.32D32.0D42.0D49.7
»dura (cranial) (mater)
  »cerebral
C70.0C79.32D32.0D42.0D49.7
»falx (cerebella) (cerebri)
C70.0C79.32D32.0D42.0D49.7
»meninges
  »brain
C70.0C79.32D32.0D42.0D49.7
»meninges
  »cerebral
C70.0C79.32D32.0D42.0D49.7
»meninges
  »crainial
C70.0C79.32D32.0D42.0D49.7
»meninges
  »intracranial
C70.0C79.32D32.0D42.0D49.7
»pia mater
  »cerebral
C70.0C79.32D32.0D42.0D49.7
»pia mater
  »cranial
C70.0C79.32D32.0D42.0D49.7
»subdural
C70.9C79.32D32.9D42.9D49.7
»tentorium (cerebelli)
C70.0C79.32D32.0D42.0D49.7

Information for Patients


Brain Tumors

A brain tumor is a growth of abnormal cells in the tissues of the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Some are primary brain tumors, which start in the brain. Others are metastatic, and they start somewhere else in the body and move to the brain.

Brain tumors can cause many symptoms. Some of the most common are

  • Headaches, often in the morning
  • Nausea and vomiting
  • Changes in your ability to talk, hear, or see
  • Problems with balance or walking
  • Problems with thinking or memory
  • Feeling weak or sleepy
  • Changes in your mood or behavior
  • Seizures

Doctors diagnose brain tumors by doing a neurologic exam and tests including an MRI, CT scan, and biopsy. Treatment options include watchful waiting, surgery, radiation therapy, chemotherapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells. Many people get a combination of treatments.

NIH: National Cancer Institute

  • Brain surgery (Medical Encyclopedia)
  • Brain surgery - discharge (Medical Encyclopedia)
  • Brain tumor - primary - adults (Medical Encyclopedia)
  • Metastatic brain tumor (Medical Encyclopedia)
  • Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
  • What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)

[Read More]

ICD-10 Footnotes

General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
  • No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
  • Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.